Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating)’s share price dropped 2.8% during trading on Monday . The stock traded as low as $1.74 and last traded at $1.77. Approximately 10,438 shares changed hands during mid-day trading, a decline of 75% from the average daily volume of 41,313 shares. The stock had previously closed at $1.82. […]
Impel NeuroPharma Inc (IMPL) Appoints Darren Cline to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Highlights Include Multiple Presentations Addressing Safety and Efficacy of TrudhesaSEATTLE, April 11, 2023 Impel Pharmaceuticals , a commercial-stage pharmaceutical company developing. | April 11, 2023